Mahmoud M. Nasser, Abd El-Aziz A. Diab, Soliman S.A. Ibrahim, Ahmed L. El-Said, Eman M.E. Mohallal, Samih I. El-Dahmy


Cerastes cerastes is the most abundant venomous snakes of the North Africa, envenoming by it inflicts local tissue damage, hemorrhage and causing severe systemic toxicity that usually lead to victim death. Therefore, the present study aimed to evaluate the toxicity of Cerastes cerastes venom on male albino rats and the ameliorative and prophylaxis role of Alkanna orientalis extract against venom toxicity. Forty-eight adult male albino rats (180±200g) were divided into 6 groups. Group I injected intraperitonial with physiological saline (100μl). Group II with Alkanna orientalis extract (250mg/kg/BW). Group III was injected with 1/10 LD50 of Cerastes cerastes venom (0.435mg/kg/BW). Group IV injected with Cerastes Cerastes venom (0.435mg/kg/BW) then immediately with Alkanna orientalis extract. Group V was given Alkanna orientalis extract orally (250mg/kg/b.wt) then after 2 hours injected with Cerastes cerastes venom (0.435 mg/kg/BW) Group VI was injected with Cerastes cerastes venom then was injected immediately with antivenom immunoglobulin (300μl). Group III  showed a significant increase (p<0.001)  in serum aspartate transaminase, alanine transaminase, alkaline phosphatase and total &direct bilirubin as well as a significant decrease(p<0.001)  in plasma prothrombin and partial thromboplastin concentration, plasma albumin, total protein, serum cholinesterase, hemoglobin, red blood cells and platelets count as compared with control group. In addition, it resulted in internal abdominal cavity hemorrhage. While, group II did not show any significant change in all previous parameters. As well as, Alkanna orientalis extract when given intraperitonial immediately or orally 2 hours before Cerastes cerastes venom as antidote, it minimize the alterations of hematological, biochemical parameters and the internal hemorrhage. By comparing groups IV and V with group VI, we found out that Alkanna orientalis extract could be considered more effective antidote than antivenom immunoglobulin for Cerastes cerastes venom toxicity. In conclusion, Alkanna orientalis extract showed a new therapeutic and prophylaxis agents against Cerastes cerastes venom toxicity.

Key words: Cerastes cerastes; Alkanna orientalis; Boraginaceae family; venom toxicity; haematological effect

Full Text:



(1) Molander M, Saslis-Lagoudakis CH, Jager AK, Ronsted N. Cross cultural comparison of medicinal floras used against snakebites. J Ethnopharmacol 2012; 139: 863–72.

(2) Kasturiratne A, Wickremasinghe AR , Silva N, Gunawardena NK, Pathmeswaran A, Premaratna R, Savioli L, Lalloo DG, de Silva HJ. The global burden of snakebite: A literature analysis and modelling based on regional estimates of enven-oming and deaths. PloS Med 2008; 5: 1591–604.

(3) Saleh MA. Amphibians and Reptiles of Egypt. Publication of National Biodiversity Unit No. 6, Ministry of State Environmental Affairs, Egyptian Environmental Affairs Agency, Egypt, 1997.

(4) Anai K, Sugiki M, Yoshida E, Maruyama M. Neutralization of a snake venom hemorrhagic metalloproteinase prevents coagulopathy after subcutaneous injection of Bothrops jararaca venom in rats. Toxicon 2002; 40: 63–8.

(5) Kebir-Chelghoum H, Laraba-Djebari F. Cytotoxicity of Cerastes cerastes snake venom: Involvement of imbalanced redox status. Acta Trop 2017; 173: 116–24.

(6) Ibrahim AM, ElSefi TT, Ghanem M, Fayed AM, Shaban NA. A horned viper bite victim with PRES. Case reports in neurological medicine. 2017; 2017. Article ID 1835796, 6 pages

(7) Leon G, Valverde JM, Rojas G, Lomonte B, Gutierrez JM. Comparative study on the ability of IgG and Fab sheep antivenoms to neutralize local hemorrhage, edema and myonecrosis induced by Bothrops asper (terciopelo) snake venom. Toxicon 2000; 38: 233–4.

(8) Girish KS, Kemparaju K. Inhibition of Naja naja venom hyaluronidase role in the management of poisonous bite. Life Sci 2006; 78: 1433–40.

(9) Girish KS, Kemparaju K. The magic glue hyaluronan and its eraser hyaluronidase: a bio-logical overview .Life Sci 2007; 80 (21): 1921–43.

(10) De Smet, PA. The role of plant derived drugs and herbal medicines in health care .Drugs 1997; 54 (6): 801–40.

(11) (11)Hasani-Ranjbar S, Larijani B, Abdollahi M. A systemic review of potential herbal sources of future drugs effective in oxidant related diseases. Allergy Drug targets 2009; 8 (1): 2–10.

(12) Moallem SA, Hosseinzadeh H, Ghoncheh F.Evaluation of Antidepressant Effects of Aerial Parts of Echium vulgare on Mice. Iran J Basic Med Sci 2007; 10 (3): 189––96.

(13) Aung HT, Nikai T, Niwa M, Takaya Y. Rosmarinic acid in inhibits Argusia argentea snake venom-induced hemorrhage. J Nat Med 2010; 64 (4): 482––6.

(14) Sekhar J, Penchala G, Sudarsanam G, Prasad GP. Ethnic information on treatment for snake bites in kadapa district of Andhra Pradesh. life Science Leafl 2011: 12; 368–75.

(15) Gomes A, Das R, Sarkhel S, Mishra R, Mukherjee S, Bhattacharya S, Gomes A. Herbs and herbal constituents active against snakebite. Indian J Exp Biol 2010; 48 (9): 865-78.

(16) Lopez-Martnez JC, Campara-Madrid P, Guil-Guerrero JL. Llinolenic acidenrichment from Borago officinalis and Echium fastuosum seed oils and fatty acids by low temperature crystallization. J Biosci Bioeng 2004; 97 (5): 294–8.

(17) Abbaszadeh S, Radjabian T, Taghizadeh M, Fazeli F, Salmaki Y.Characterization of fatty acids in different organs of some Iranian Echium plants. J Med Plants Res 2011; 5 (19): 4814–21.

(18) Kuhnt K, Degen C, Jaudszus A, Jahreis G. Searching for health beneficial n-3 and n-6 fatty acids in plant seeds. Eur J Lipid Sci Technol 2012; 114 (2): 153–60.

(19) Petersen M, Simmonds MS. Rosmarinic acid. Phytochem 2003; 62 (2): 121–5.

(20) Ticli FK, Hage LI, Cambraia RS, Pereira PS, Magro AJ, Fontes MR, Stábeli RG, Giglio JR, França SC, Soares AM, Sampaio SV. Rosmarinic acid, a new snake venom phospholipase A2 inhibitor from Cordia verbenacea (Boraginaceae): antiserum action potentiation and molecular interaction. Toxicon 2005; 46 (3): 318–27.

(21) El Sohly HN, El-Feraly FS, Joshi AS, Walker LA. Antiviral flavonoids from Alkanna orientalis. Planta Medica 1997; 63: 384.

(22) Gopi K, Renu K, Jayaraman G. Inhibition of Naja naja venom enzymes by the methanolic extract of Leucas aspera and its chemical profile by GC-MS. Toxicol Rep 2014; 1: 667–73.

(23) Ramakrishnan M A . Determination of 50% endpoint titer using a simple formula. World J Virol: 2016; 5: 85–6.

(24) Sukhdev SH, Suman PS, Gennaro L, Dev DR. Extraction technologies for medicinal and aromatic plants. United Nation Industrial Deve-lopment organization and the international center for Science and High Technology. 2008; 116.

(25) Reitman S, Frankel SA. Colorimetric method for the determination of serum glutamic oxaloacetic and glutamic transaminase. Amer Clin Pathology 1957; 28 (1): 56–63.

(26) Moss DW, Henderson AR, Kachmar JF. Enzymes. In: Tietz NW, ed. Fundamentals of Clinical Chemistry. 3rd ed. Philadelphia: WB Saunders 1987: 346–421.

(27) Doumas B, Watson W. Enzymatic colorimetric method of albumin. Clin Chem Acta 1971; 31: 87–96.

(28) Tietz NW. Fundamentals of Clinical Chemistry: 2 nd ed. Tietz NW, editor, 1994, pp 692.

(29) ElImanGL, Courtney KD, Andrea V, Featherstone RM. A new and rapid colorimetric determination of acetyicholinesterase activity. Biochem Pharmacol 1961; 7: 88–95.

(30) Colman RW, Hirsh J, Marder VJ, Salzman EW. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Philadelphia: JB Lippincott, 1994: 1. 21.

(31) Van Kampen EJ, Zijlstra WG. Determination of hemoglobin and its derivatives. Adv Clin Chem. 1965; 8: 141–87.

(32) Dacie J V, Lewis S M: Practical haematology. 7th Edition (1991). Churchill Living Stone, Edinburgh, pp. 41–57.

(33) Duncan DB. Multiple range and multiple F tests. Biometrics 1955; 11 (1): 1–42.

(34) Armitage P, Berry G. Statistical Methods in Medical Research. Boston MA: Blackwell Scientific, Oxford, UK, 1987; 559.

(35) Salman MM. Effects of Different Doses of Cerastes cerastes Crude Venom on Biochemical Parameters in Serum of Guinea pigs at different times. Biological Forum 2014; 6 (2): 329–39.

(36) Al-Sadoon MK, Abdel Moneim AE, Diab MM, Bauomy AA. Hepatic and renal tissue damages induced by Cerastes cerastes gasperetti crude venom. Life Sci J 2013; 10 (4): 191–7.

(37) Shaban EA, Hafez MN. Ability of gamma irradiated polyvalent antivenin to neutralize the toxicity of the Egyptian cobra (Naja haje) venom. Egypt J Hosp Med 2003; 13: 135–52.

(38) Abdel Moneim AE, Othman MS, Mohmoud SM, El-Deib KM. Pomegranate peel attenuates aluminum-induced hepatorenal toxicity. Toxicol Mech Methods 2013; 23 (8): 624–33.

(39) Mohamed AH, Fouad S, El-Assar AM, Salem A, Abdel Aal A, Hassan AA, Zahran F, Abbas N. Effects of several snake venoms on serum and tissue transaminase, alkaline phosphatase and lactate dehydrogenase. Toxicon1981; 19 (5): 605–.

(40) Al-Sadoon MK, Fahim APossible recovery from an acute envenomation in male rats with LD50 of Echis coloratus crude venom: IA seven days hematological follow-up study. Saudi Biol Sci 2012; 19 (2): 221–7.

(41) Al-Quraishy S, Dkhill MA, Abdel Moneim AE. Hepatotoxicity and oxidative stress induced by Naja haje crude venom. Venom Anim Toxins Incl Trop Dis 2014; 20 (1): 42–52.

(42) Soares AM, Giglio JR. Chemical modifications of phospholipases A2 from snake venoms: effects on catalytic and pharmacological properties. Toxicon 2003: 42 (8), 855–68.

(43) Kini RM. Excitement ahead: structure, function and mechanism of snake venom phospholipase A2 enzymes. Toxicon 2003; 42 (8): 827–40.

(44) Schneemann M, Cathomas R, Laidlaw ST, El Nahas AM, Theakston RD, Warrell DA.Life-threatening envenoming by the Saharan horned viper (Cerastes cerastes) causing micro-angiopathic haemolysis, coagulopathy and acute renal failure: clinical cases and review2004. QJM 97; (11): 717–27.

(45) Chang CC. The action of snake venoms on nerve and muscle. In snake venoms, handbook of experimental pharmacology. Vol. 52. (ed: C.Y.Lee), pp. 309–376. Springer-Verlag, Berlin, , Heidelberg, New York.

(46) Diab AA, Dahmy SI , Soliman. SAI and Nasser M M. The protective role of Echium humile extract against toxicity induced by insecticide (malathion) in male albino rats. Journal of American Science 2013; 9 (11): 259–67.

(47) Izidoro LFM, Rodrigues VM , Rodrigues RS, Ferro EV, Hamaguchi A , Giglio JR, Homsi-Brandeburgo MI. Neutralization of some hematological and hemostatic alterations induced by neuwiedase, a metalloproteinase isolated from Bothrops neuwiedi pauloensis snake venom, by the aqueous extract from Casearia mariquitensis (Flacourtiaceae). Biochimie 2003; 85 (7): 669–75.

(48) Kini R M. Toxins in thrombosis and haemostasis: potential beyond imagination. J Thromb Haemost 2011; 9: 195–208.

(49) Pidde-Queiroz, G , Magnoli FC, Portaro FCV, Serrano SMT, Lopes AS, Leme AF, van den Berg CW, Tambourgi DV. PI snake venom metallo-proteinase is able to activate the complement system by direct cleavage of Central components of the Cascade. PLoS Negl Trop Dis 2013; 7 (10): 2519.

(50) Amin MR, Mamun SMH, Rashid R, Rahman M, Ghose A, Sharmin S, Rahman MR, Faiz MA.Anti-snake venom: use and adverse reaction in a snake bite study clinic in Bangladesh. J Venom Animals Toxins Incl Trop Dis 2008; 14 (4): 660–72.

(51) Makran B, Fahmi L, Pla D, Sanz L, Oukkache N, Lkhider M, Ghalim N, Calvete JJ. Snake venomics of Macrovipera mauritanica from Morocco, and assessment of the para-specific immunoreactivity of an experimental monospecific and a commercial antivenoms. J Proteomics 2012; 75 (8): 2431–41.

(52) Morita T. Structure-function relationships of C-type lectin-related proteins. Pathophysiol Haemost Thromb 2005; 34 (4-5): 156–9.

(53) Venkatesh M, Gowda V. Synergistically acting PLA2: peptide hemmorhagic complex from Daboia russelii venom. Toxicon 2013; 73: 111–20.

(54) Fox JW, Serrano SM. Timeline of key events in snake venom metalloproteinase research. J Proteomics 2009; 72 (2): 200 - 209.

(55) Sajevic T, Leonardi A, Križaj I . Haemostatically active proteins in snake venoms. Toxicon 2011; 57 (5): 627–45.

(56) Persson H. Envenoming by European vip-ers: antivenom treatment-influence on morbidity. Przeglad Lekarski. 2001; 58 (4): 223–5.



  • There are currently no refbacks.